Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli et al. · Journal of Clinical Oncology · 2021 · 376 citations · Full text

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Michelle Wilson, Éric Pujade-Lauraine, Daisuke Aoki et al. · Annals of Oncology · 2016 · 285 citations · Full text

Gynecological Surgery, Medicine, Gynecologic Cancer Intergroup +8

ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

Jonathan A. Ledermann, Xavier Matías‐Guiu, Frédéric Amant et al. · Annals of Oncology · 2024 · 223 citations · Full text

Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.

Andreas du Bois, Jalid Sehouli, Ignace Vergote et al. · Journal of Clinical Oncology · 2020 · 150 citations · Full text

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

Amer Karam, Jonathan A. Ledermann, Jae‐Weon Kim et al. · Annals of Oncology · 2017 · 149 citations · Full text

Medicine, Gynecologic Cancer Intergroup, Cancer Management +8